OUTLINE OUTLINE. KDIGO Modification (2006) Chronic Kidney Disease (CKD): Classification-(NKF-K/DOQI-2002)

Size: px
Start display at page:

Download "OUTLINE OUTLINE. KDIGO Modification (2006) Chronic Kidney Disease (CKD): Classification-(NKF-K/DOQI-2002)"

Transcription

1 Changes in Serum Creatinine: Pitfalls in Evaluating Patients for Chronic Kidney Disease (CKD) Richard J. Glassock, MD, MACP Emeritus Professor- The Geffen School of Medicine at UCLA 5 rd Raymond Kay Internal Medicine Symposium Palm Springs, CA November, 9 OUTLINE Definitions of CKD Estimation of GFR by formulas Application of Definitions to the Role of proteinuria (albuminuria) in diagnosis and prognosis of CKD in the elderly Conclusions and OUTLINE Definitions of CKD Estimation of GFR by formulas Application of Definitions to the Role of proteinuria (albuminuria) in diagnosis's and prognosis in the elderly Conclusions and Chronic Kidney Disease (CKD): Classification-(NKF-K/DOQI-) Stage Kidney egfr Damage (ml/min/.7m ) NA -59 NA NA <5 (or dialysis) (calculated from serum creatinine level by the abbreviated MDRD equation; NA= not applicable: findings must persist for months) KDIGO Modification (6) Suffix T added to Stages - if recipient of a renal transplant Suffix D added to Stage 5 if receiving Dialysis Question #: An Woman with a low egfr A 75 year old widow is seen by her general internist for a pre-operative evaluation connected with a planned left hip replacement for debilitating osteoarthritis and necrosis of the femoral head. Other than impaired vision from cataracts she feels well. There is no personal or family history of kidney disease. She takes an occasional NSAID for pain, and regular ergocalciferol and calcium supplements.

2 Question # Her physical examination reveals a thin (weight= 5 kg, height.6m), but otherwise healthy appearing elderly woman with a blood pressure of /78mmHg. There is no edema or JV distension. No abdominal bruits. Pulses are full and intact. Pain on pressure over the left hip is found. Question # Laboratory studies reveal a serum creatinine of.5mg/dl (a calculated egfr= 5ml/min/.7m according to the report). Hemoglobin is.6gms/dl, serum albumin is.g/dl, the blood sugar (fasting) is 9mg/dL,and serum cholesterol is 85mg/dL. All other biochemical studies are also normal. A urinalysis is negative for protein and blood An EKG and chest X-Ray are normal Question # Based on an egfr of 5ml/min/,7 m the patient is told she has Chronic Kidney Disease (CKD), Stage. Which ONE of the following would you recommend now? A. Perform metabolic investigations, including a,5 and 5-hydroxy Vitamin D level, parathyroid hormone B. Order an abdominal ultrasound and CT scan C. Refer to a Nephrologist for further evaluation of CKD D. Reassure her that she can undergo her planned hip surgery as scheduled E. Cancel her scheduled hip surgery Question # The correct answer is D The patient has normal egfr for her age and gender and does not have CKD CKD-NHANES Prevalence of CKD (KDOQI)Stage by Age (999-) Prevalence (%) % 5% % 5% % 5% % 5% % Age Group (years) CKD-NHANES: Characteristics of the Staged Populations using KDOQI () Stages and (8% of Total) % had abnormal albuminuria (by definition)-88% had microalbuminuria and % had macroalbuminuria Stage (59% of Total) 67% had no abnormal proteinuria (not needed for definition) Stage (.8% of Total) % had no abnormal proteinuria Total Stage - (% of total) M/F ratio =.7 87% had no abnormal proteinuria

3 Chronic Kidney Disease (CKD): UK (NICE) Classification Stage and - Same as KDOQI Stage - Divided into parts: > Stage A (egfr= -59ml/min/.7m) > Stage B (egfr= -9ml/min/.7m) > Stages A/B designated as proteinuria + (p+, UAE=>5mg/d; UACR= >.5) or negative (p-, UAE= <5mg/d; UACR= <.5)) Stage - Same as KDOQI Stage 5- Same as KDOQI (Eight Stages total) Chronic Kidney Disease (CKD): Kaiser-Permanente Definition (Rutkoski et al AJKD 5:s86-s99, 9) Stage and - macroalbuminuria only; egfr criteria same as KDOQI Stage - egfr threshold= egfr + age/ <85ml/min/.7m but >ml/min/.7 m Stage - same as KDOQI Stage 5- Same as KDOQI CKD Prevalence by Modified and Standard KDOQI Criteria (Rutkowski, et al AJKD, 9; Coresh, et al JAMA, 8).%.%.% 8.% 6.%.%.%.% Stage Stage Stage Stage Stage 5 Stages -5 Chronic Kidney Disease (CKD): Winearls-Glassock Classification (Winearls C, Glassock R. KI- 75:9, 9) Stage - Collapses KDOQI Stage and into single stage and eliminates microalbuminuria; egfr > 5 th percentile for age and gender; evidence of renal disease (urinalysis, imaging/biopsy) Stage - egfr < 5 th percentile fro age and gender but >ml/min/.7m; same as Stage above Stage - egfr 5-ml/min/.7m (irrespective of age or gender) Stage - egfr <5ml/min/.7m (not on RRT) Stage 5- Dialysis dependent DEFINITIONS OF CKD Confused? Clarity may come from an International Consensus Conference to be Held in London, UK under the auspices of KDIGO on October -5, 9 OUTLINE Definitions of CKD Estimation of GFR by formulas Application of Definitions to the Role of proteinuria (albuminuria) in diagnosis's and prognosis in the elderly Conclusions and

4 egfr (MDRD) vs mgfr (Cin) (Botev, et al, 9) Precision and Bias: egfr (MDRD) vs mgfr (Cin) (Botev R, et al CJASN :899-96, 9) 7% 6% 5% egfr % Relative % Bias/ % Precision % % -% -% <5 mgfr (ml/min/.7m) Bias (% mean difference) Precision (% one SD of mean) Classifications of CKD According to mgfr (C edta )and egfr (MDRD) (Froissart, et al. JASN, 5) (95 subjects; 995 with CKD/6 normal donors) mgfr > Stage 67% 6%.5% Stage % 6% % Stage.6% % 78% Stage.% % Stage 5 Original KDOQI +egfr (MDRS) schema overestimates prevalence of CKD (especially in older women) 5-9 <5 7%.% 79% %.% 65% NO EPIDEMIC OF CKD! OUTLINE Definitions of CKD Estimation of GFR by formulas Application of Definitions to the Role of proteinuria (albuminuria) in diagnosis's and prognosis in the elderly Conclusions and Question #- A Frail elderly lady in the ICU A 66 year old woman with uro-sepsis following a liver transplant. She is small (weight Kg), malnourished and frail. Scr=.8mg/dL egfr (MDRD)=.ml/min/.7m eccr (C-G)=.ml/min

5 Question # Which ONE of the following statements MOST accurately describes the true (actual) GFR in this patient? A. The egfr (MDRD) and eccr (C-G) accurately reflect her actual GFR B. Her actual GFR is greater than either the egfr (MDRD) or the eccr (C-G) predict C. Her actual GFR is less than either the egfr (MDRD) or eccr (C-G) predict D. The egfr (MDRD) is a more accurate estimation of the actual GFR E. The eccr (C-G) is a more accurate estimation of the actual GFR Question # The correctt answer is C A hour urine collection was performed to quantify the endogenous creatinine clearance The value was.6ml/min eccr (C-G)/endogenous Ccr=. egfr (MDRD)/endogenous Ccr=.5 (See Freedberg Kidney Int 766:9, 9) Question # GFR (Cin) According to Age- (Wesson, LG, 98) Muscle wasting (sarcopenia) markedly reduced creatinine generation, leading to overestimation of Ccr (and GFR) by both egfr (MDRD) and eccr (C-G) formulas (which rely on Scr, age, gender (and weight) only. The same thing will happen in pure vegetarians and the opposite will happen in highly muscular in individuals 6 CKD: egfr in Healthy Caucasians by Gender Males 6 Females x X = chromium EDTA clearance X = MDRD egfr 95% CIs egfr (ml/min/.7m) Age (years) egfr (ml/min/.7m) th Percentile 5 th Percentile 5 th Percentile Age (years) x x (Nijmegen Biomedical Study, 8) The case of Prof K single kidney and CKD 5

6 Percentile Charts: Useful for Following Progression of CKD Microalbuminuria: Prevalence (PREVEND, ) (N=,69) Patients who move down the percentile values (e.g. from 75th to 5th to 5 th ) have progressive disease, even if they remain in the same KDOQI stage Patients who remain in the same percentile do not have progressive disease, even if they move to higher KDOQI stages Prevalence of Microalbuminuria 8% 6% % % % 8% 6% % % % Age (years) Males Females UACR with Aging Albuminuria: Gender associated changes with Aging (Verhave JC, et al AJKD :6, ) Lean body mass (LBM; muscle mass) decreases steadily after about age years in normal subjects (around Kg/decade) Urinary creatinine excretion is tightly correlated with LBM At constant urinary albumin excretion rate, the urinary albumin to creatinine ratio increases with aging Ratio of 6 Prevalence 5 [Old (7-75 y) to Young (8- y)] Males Females UAE (- mg/d) UACR - mg/gm UACR (M=7-9mg/gm;F =5-5mg/gm) egfr does not Correlate with UAE (Cirillo M, et al. Gubbio Population Study. Arch Intern Med 68:67, 8) OUTLINE Definitions of CKD Estimation of GFR by formulas Application of Definitions to the Role of proteinuria (albuminuria) in diagnosis's and prognosis in the elderly Conclusions and 6

7 Question # In order to properly utilize egfr or Albuminuria to diagnose CKD one should adjust for the effects of gender and normal aging A 68 year old woman is discovered to have Stage CKD (by KDOQI-CKD Classification Criteria) following routine outpatient serum creatinine test. She is a non-smoker, has no diabetes and has no family history of heart disease Laboratory Tests: FBS- mg/dl, Total Cholesterol 7mg/dL, Uric acid.mg/dl, egfr (MDRD) 55ml/min/.7m, urinalysis negative protein/blood by dipstick, urinary albumin/creatinine ratio= 7mg/gm creatinine Question # Which ONE of the following best characterizes her risk for a subsequent cardiovascular (CV) event compared to a similar patient with an egfr (MDRD) >6ml/min/.7m? A. She is at increased risk for a fatal/non-fatal CV event over the next 5- years B. She is at decreased risk for a fatal/non-fatal CV event over the next 5- years C. Her risk for a fatal/non-fatal CV event is neither decreased or increased Question # The Correct answer is C- In the absence of proteinuria (albuminuria) a low GFR (in the normal range for her age and gender) does not constitute a significant CV risk factor egfr and Albuminuria in Prediction of ESRD and CVD Albuminuria is a better predictor of risk of ESRD and CVD events than egfr Non-albuminuric Stage CKD (Stage A, p-) uncommonly progresses to ESRD and has a low relative risk of CVD in subjects over 65 years of age Hazard Ratios for ESRD by egfr and Urinary Albumin/Creatinine Ratio (Hallan S, et al JASN April, 9) 5 5 Hazard Ratio 5 ( years) 5 5 > egfr (ml/min/.7m) Normoalbuminuria Microalbuminruia Macroalbuminuria 7

8 Change in egfr over time in CKD (Halbesma N, et al, PREVEND. JASN 7:58-59, 6) All-Cause Mortality and Proteinuria (At same egfr strata) Taiwan Health Management Institution Study; Lancet 8 6 Change in egfr (ml/min/.7m) over years Hazard Ratio 5 egfr <5th percentile (% albuminuria) Hematuria (5% albuminuria) Macroalbuminuria (5% egfr < 5th percentile) egfr (ml/min/.7m Normal Proteinuria Minimal Proteinuria Overt Proteinuria CVD and CKD: Cross-Classification of egfr and Microalbuminuria: Effect on CV Event Risk (Foster MC, et al Arch Intern Med 67:86-9, 7) CKD Stage Risk of Cardiovascular Disease (Brantsma AH, et al and PREVEND. NDT, 8) (n= with CKD) CV Events (Hazard Ratio after adjustment for comorbidity-95% CI) Microalbuminuria Absent Present egfr Not Reduced.. (ref) (.8-.8) Reduced.9.6 (.6-.) (.-.5) (<6ml/min/.7m in males; <59ml/min/.7m in females) Hazard Ratio for CV Events (no CKD=.) Stage Stage Stage (All) Stage (UAE Stage (UAE <mg/d) >mg/d) CKD Stage PREVEND egfr MDRD vs CVD events (Van der Velde M, et al PREVEND-ASN 8) PREVEND egfr (CyC), Ccr (Age > 6 years): Kidney Center UMCG 8 HR 6 <6 Age < 6 yrs 9-6 >9 <6 Age > 6 yrs 9-6 >9 MA+ Kidney Center UMCG,5,5 HR,5,5 <6 egfr CysC 9-6 >9 MA-,5,5 HR,5 MA+,5 MA- Creatinine clearance <6 9-6 >9 8 HR 6 MA+ MA- MA- MA+ 8

9 egfr and Diagnosis of CKD: An Illustration A 5 year old man with an egfr of 55 ml/min/.7m is 5% below the median for his age and -5 ml/min/.7m below the 5th percentile for age and gender A 75 year old man with an egfr of 55ml/min/.7m is % below the median for his age and +5 ml/min/.7m above the 5th percentile for age and gender WHICH ONE HAS SIGNIFiCANT CKD? Question # Patient A a 5 year old man with an egfr of 55 ml/min/.7m (p-) is 5% below the median for his age and -5 ml/min/.7m below the 5th percentile for age and gender Patient B- a 75 year old man with an egfr of 55 ml/min/.7m (p-) is % below the median for his age and +5 ml/min/.7m above the 5th percentile for age and gender Question # Which ONE of the patients described has significant CKD? A. Patient A only B. Patient B only C. Patient A and B D. Neither Patient A or B OUTLINE Definitions of CKD Estimation of GFR by formulas Application of Definitions to the Role of proteinuria (albuminuria) in diagnosis's and prognosis in the elderly Conclusions and CONCLUSIONS Use of egfr alone to diagnose CKD leads to many false positives particularly in elderly females No clear rationale for separating Stage and in KDOQI and NICE Albuminuria is a much stronger risk factor than egfr in predicting outcome (ESRD and CVD), but values must be adjusted for age and gender RECOMMENDATIONS New and uniform criteria, with adjustment for effects of age and gender, for diagnosing CKD are needed Assessment of Albuminuria (UACR, second morning void), adjusted for gender and age, should be used for early detection of high risk subjects (at any age) and for prediction ESRD and CVD risk. Prospective trials are needed to assess the cost-effectiveness of detection (screening) strategies based on albuminuria 9

10 PROPOSED NEW DEFINITIONS OF CKD BASES ON egfr and UACR CRITERIA THANK YOU CKD-- No CKD- unless imaging, urinalysis or biopsy abnormal- Low Risk of CVD/ESRD CKD-- Possible CKD- depends on Age <65 y, imaging, urinalysis or pathology abnormal- Moderate Risk of CVD/ESRD - Definite CKD- without need for abnormal imaging, urinalysis or pathology- High Risk of CVD/ESRD A Grid For Diagnosis and Prognosis Of Chronic Kidney Disease (CKD) A Grid For Diagnosis and Prognosis (CVD-RR) Of Chronic Kidney Disease (CKD) A A A A A A G (9+) G (6-89) G a (5-59) G b (-) G (5-9) G 5 (<5) (<mg/gm) CKD- CKD- CKD-/ CKD- CKD- (-mg/gm) CKD-/ CKD- CKD- CKD- (>mg/gm) G (9+) G (6-89) G a (5-59) G b (-) G (5-9) G 5 (<5) (<mg/gm) > (-mg/gm) > (>mg/gm) > Classification of CKD: The Future? Refinement of a G (egfr)-a (Albuminuria) stratification (8 cells) Sub-stratification by Age (< or > 65 years) and Gender (M/F) Relative and Absolute Risks of All-Cause mortality, CVD mortality, ESRD, Progressive CKD by G-A Stage Risk Scoring by G-A Stage, modified by Age and Gender (Low, Medium, High) Example 5 year old man with Autosomal Dominant Polycystic Kidney Disease; egfr 6ml/min/.7m, UACR 5mg/gm, bilaterally enlarged Cystic kidneys by ultrasound CKD--G A ; RR=- for CVD; ADPKD

Calculating the stage of Renal Disease

Calculating the stage of Renal Disease Calculating the stage of Renal Disease When the Refresh Template/Check Labs button is depressed, the box next to MDRD, will be automatically checked. In order to use this in the calculation of the stage

More information

Understanding diabetes Do the recent trials help?

Understanding diabetes Do the recent trials help? Understanding diabetes Do the recent trials help? Dr Geoffrey Robb Consultant Physician and Diabetologist CMO RGA UK Services and Partnership Assurance AMUS 25 th March 2010 The security of experience.

More information

Albuminuria versus GFR as markers of diabetic CKD progression

Albuminuria versus GFR as markers of diabetic CKD progression Albuminuria versus GFR as markers of diabetic CKD progression KDIGO Controversies Conference: Diabetic Kidney Disease New Delhi, March 2012 Richard J MacIsaac PhD FRACP Director of Endocrinology & Diabetes,

More information

Definition, Prevalence, Pathophysiology and Complications of CKD. JM Krzesinski CHU Liège-ULg Core curriculum Nephrology September 28 th 2013

Definition, Prevalence, Pathophysiology and Complications of CKD. JM Krzesinski CHU Liège-ULg Core curriculum Nephrology September 28 th 2013 Definition, Prevalence, Pathophysiology and Complications of CKD JM Krzesinski CHU Liège-ULg Core curriculum Nephrology September 28 th 2013 KI supplements January 2013 Objectives of the course on CKD:

More information

Diabetes and the Kidneys

Diabetes and the Kidneys Diabetes and the Kidneys Aim(s) and objective(s) This guideline focuses on the detection, prevention, and management of kidney disease in people with diabetes. The management of end-stage renal disease

More information

Estimated GFR Based on Creatinine and Cystatin C

Estimated GFR Based on Creatinine and Cystatin C Estimated GFR Based on Creatinine and Cystatin C Lesley A Stevens, MD, MS Tufts Medical Center, Tufts University School of Medicine Boston MA Chronic Kidney Disease-Epidemiology Collaboration UO1 DK 053869,

More information

Renal Disease in Type 2 Diabetes Mellitus

Renal Disease in Type 2 Diabetes Mellitus Renal Disease in Type 2 Diabetes Mellitus 6th Collaborative DiGP/HSE/UCC Conference 25 th September 2013 Dr. Eoin O Sullivan Consultant Endocrinologist Bon Secours Hospital Cork Case 69 year old woman

More information

Systolic Blood Pressure Intervention Trial (SPRINT) Principal Results

Systolic Blood Pressure Intervention Trial (SPRINT) Principal Results Systolic Blood Pressure Intervention Trial (SPRINT) Principal Results Paul K. Whelton, MB, MD, MSc Chair, SPRINT Steering Committee Tulane University School of Public Health and Tropical Medicine, and

More information

Diabetic Nephropathy

Diabetic Nephropathy Diabetic Nephropathy Kidney disease is common in people affected by diabetes mellitus Definition Urinary albumin excretion of more than 300mg in a 24 hour collection or macroalbuminuria Abnormal renal

More information

Prevalence and risk factor of chronic kidney disease in elderly diabetic patients in Korea 성애병원 내과 김정한

Prevalence and risk factor of chronic kidney disease in elderly diabetic patients in Korea 성애병원 내과 김정한 Prevalence and risk factor of chronic kidney disease in elderly diabetic patients in Korea 성애병원 내과 김정한 Introduction CKD의 정의와 egfr의 측정 CKD의 risk factor와 mechanism 한국의 CKD prevalence 와 prognosis CKD의 치료와

More information

GFR (Glomerular Filtration Rate) A Key to Understanding How Well Your Kidneys Are Working

GFR (Glomerular Filtration Rate) A Key to Understanding How Well Your Kidneys Are Working GFR (Glomerular Filtration Rate) A Key to Understanding How Well Your Kidneys Are Working www.kidney.org National Kidney Foundation's Kidney Disease Outcomes Quality Initiative Did you know that the National

More information

Chronic Kidney Disease and the Electronic Health Record. Duaine Murphree, MD Sarah M. Thelen, MD

Chronic Kidney Disease and the Electronic Health Record. Duaine Murphree, MD Sarah M. Thelen, MD Chronic Kidney Disease and the Electronic Health Record Duaine Murphree, MD Sarah M. Thelen, MD Definition of Chronic Kidney Disease (CKD) Defined by the National Kidney Foundation Either a decline in

More information

Nierfunctiemeting en follow-up van chronisch nierlijden

Nierfunctiemeting en follow-up van chronisch nierlijden Nierfunctiemeting en follow-up van chronisch nierlijden 12 Jan 2016 Patrick Peeters, M.D. Dept Nephrology Ghent University Hospital Plan of presentation 1/ Renal function determination: Measured GFR Estimated

More information

Diabetic nephropathy is detected clinically by the presence of persistent microalbuminuria or proteinuria.

Diabetic nephropathy is detected clinically by the presence of persistent microalbuminuria or proteinuria. Kidney Complications Diabetic Nephropathy Diabetic nephropathy is detected clinically by the presence of persistent microalbuminuria or proteinuria. The peak incidence of nephropathy is usually 15-25 years

More information

Prediction of Kidney Disease Progression in Patients with Diabetes

Prediction of Kidney Disease Progression in Patients with Diabetes Prediction of Kidney Disease Progression in Patients with Diabetes John Arthur, MD, PhD Medical University of South Carolina SEKDC Meeting September 8, 2012 Objectives Understand the importance of predicting

More information

Models of Chronic Kidney Disease Care and Initiation of Dialysis. Dr Paul Stevens Kent Kidney Care Centre East Kent Hospitals, UK

Models of Chronic Kidney Disease Care and Initiation of Dialysis. Dr Paul Stevens Kent Kidney Care Centre East Kent Hospitals, UK Models of Chronic Kidney Disease Care and Initiation of Dialysis Dr Paul Stevens Kent Kidney Care Centre East Kent Hospitals, UK Early Crash Landings Talk Outline Pathways & Definitions Guideline recommendations

More information

In 2002 the National Kidney Foundation s

In 2002 the National Kidney Foundation s VOL xx, NO xx, MONTH 2009 POSITION STATEMENT Definition and Classification of CKD: The Debate Should Be About Patient Prognosis A Position Statement From KDOQI and KDIGO In 2002 the National Kidney Foundation

More information

Diagnosis, classification and staging of chronic kidney disease

Diagnosis, classification and staging of chronic kidney disease Diagnosis, classification and staging of chronic kidney disease Date written: July 2012 Author: David Johnson DIAGNOSIS GUIDELINES a. We recommend that chronic kidney disease (CKD) be diagnosed in all

More information

Guideline for Microalbuminuria Screening

Guideline for Microalbuminuria Screening East Lancashire Diabetes Network Guideline for Microalbuminuria Screening Produced by: Task and Finish Group, Clinical Standards Group Produced: August 2006 Approved by: East Lancashire Diabetes Network

More information

Identifying and treating long-term kidney problems (chronic kidney disease)

Identifying and treating long-term kidney problems (chronic kidney disease) Understanding NICE guidance Information for people who use NHS services Identifying and treating long-term kidney problems (chronic kidney disease) NICE clinical guidelines advise the NHS on caring for

More information

Chronic Kidney Disease (CKD) Algorithm. Chronic Kidney Disease (CKD) Algorithm Page 1

Chronic Kidney Disease (CKD) Algorithm. Chronic Kidney Disease (CKD) Algorithm Page 1 Chronic Kidney Disease (CKD) Algorithm Chronic Kidney Disease (CKD) Algorithm Page 1 Chronic Kidney Disease (CKD) Algorithm (See NICE Clinical Guideline CG73 1 and Quality Standards 2 ) Who should have

More information

KDIGO THE GEORGE INSTITUTE FOR GLOBAL HEALTH. Antiocoagulation in diabetes and CKD Vlado Perkovic

KDIGO THE GEORGE INSTITUTE FOR GLOBAL HEALTH. Antiocoagulation in diabetes and CKD Vlado Perkovic THE GEORGE INSTITUTE FOR GLOBAL HEALTH Antiocoagulation in diabetes and CKD Vlado Perkovic Executive Director, George Institute Australia Professor of Medicine, University of Sydney Affiliated with the

More information

OUTPATIENT MANAGEMENT OF CHRONIC KIDNEY DISEASE. Jeanie Park, MD MS Assistant Professor Renal Division Emory University School of Medicine

OUTPATIENT MANAGEMENT OF CHRONIC KIDNEY DISEASE. Jeanie Park, MD MS Assistant Professor Renal Division Emory University School of Medicine OUTPATIENT MANAGEMENT OF CHRONIC KIDNEY DISEASE Jeanie Park, MD MS Assistant Professor Renal Division Emory University School of Medicine Disclosures None Goals Background and staging Strategies to slow

More information

InDependent Diabetes Trust

InDependent Diabetes Trust InDependent Diabetes Trust Kidneys and Diabetes Updated July 2015 Registered Company Number 3148360 Registered Charity No 1058284 Contents Introduction Healthy Kidneys Kidney disease and diabetes The use

More information

Diabetes and Your Kidneys

Diabetes and Your Kidneys American Kidney Fund reaching out giving hope improving lives Diabetes and Your Kidneys reaching out giving hope improving lives Diabetes: The #1 Cause of Kidney Failure Your doctor told you that you have

More information

How To Determine The Prevalence Of Microalbuminuria

How To Determine The Prevalence Of Microalbuminuria Research Journal of Pharmaceutical, Biological and Chemical Sciences Prevalence of Microalbuminuria in relation to HbA1c among known Type2 Diabetic Patients in Puducherry population Muraliswaran P 1 *,

More information

How To Know If You Have Microalbuminuria

How To Know If You Have Microalbuminuria 3 PREVALENCE AND PREDICTORS OF MICROALBUMINURIA IN PATIENTS WITH TYPE 2 DIABETES MELLITUS: A CROSS-SECTIONAL OBSERVATIONAL STUDY Dr Ashok S Goswami *, Dr Janardan V Bhatt**; Dr Hitesh Patel *** *Associate

More information

High Blood Pressure and Kidney Disease

High Blood Pressure and Kidney Disease High Blood Pressure and Kidney Disease National Kidney and Urologic Diseases Information Clearinghouse U.S. Department of Health and Human Services NATIONAL INSTITUTES OF HEALTH The kidneys play a key

More information

CHRONIC KIDNEY DISEASE MANAGEMENT GUIDE

CHRONIC KIDNEY DISEASE MANAGEMENT GUIDE CHRONIC KIDNEY DISEASE MANAGEMENT GUIDE Outline I. Introduction II. Identifying Members with Kidney Disease III. Clinical Guidelines for Kidney Disease A. Chronic Kidney Disease B. End Stage Renal Disease

More information

Age- and gender-specific reference values of estimated GFR in Caucasians: The Nijmegen Biomedical Study

Age- and gender-specific reference values of estimated GFR in Caucasians: The Nijmegen Biomedical Study original article http://www.kidney-international.org & 2007 International Society of Nephrology see commentary on page 534 Age- and gender-specific reference values of estimated GFR in Caucasians: The

More information

Chronic Kidney Disease: A New Classification and Staging System

Chronic Kidney Disease: A New Classification and Staging System Clinical Review Article Series Editor: Mark A. Perazella, MD, FACP Chronic Kidney Disease: A New Classification and Staging System Mark A. Perazella, MD, FACP Robert F. Reilly, MD Chronic kidney disease

More information

PHARMACOLOGICAL Stroke Prevention in Atrial Fibrillation STROKE RISK ASSESSMENT SCORES Vs. BLEEDING RISK ASSESSMENT SCORES.

PHARMACOLOGICAL Stroke Prevention in Atrial Fibrillation STROKE RISK ASSESSMENT SCORES Vs. BLEEDING RISK ASSESSMENT SCORES. PHARMACOLOGICAL Stroke Prevention in Atrial Fibrillation STROKE RISK ASSESSMENT SCORES Vs. BLEEDING RISK ASSESSMENT SCORES. Hossam Bahy, MD (1992 2012), 19 tools have been identified 11 stroke scores 1

More information

UCSF Kidney Transplant Symposium 2012

UCSF Kidney Transplant Symposium 2012 UCSF Kidney Transplant Symposium 2012 Nutrition Fitness in Kidney Transplant Mary Ellen DiPaola, RD, CDE UCSF Outpatient Dietitian Goal of Nutrition Fitness for Transplant Nutritional guidance of pre-

More information

KDIGO CLINICAL PRACTICE GUIDELINE FOR LIPID MANAGEMENT IN CHRONIC KIDNEY DISEASE. Supplemental Tables November 2013

KDIGO CLINICAL PRACTICE GUIDELINE FOR LIPID MANAGEMENT IN CHRONIC KIDNEY DISEASE. Supplemental Tables November 2013 KDIGO CLINICAL PRACTICE GUIDELINE FOR LIPID MANAGEMENT IN CHRONIC KIDNEY DISEASE Supplemental Tables November 2013 Suppl Table 1: Summary table of RCT examining the effect of exercise in CKD 5HD patients

More information

10/27/2010. CKD in the United States. Management of The Patient With Chronic Kidney Disease. CKD Patients Are More Likely to Die Than Progress to ESRD

10/27/2010. CKD in the United States. Management of The Patient With Chronic Kidney Disease. CKD Patients Are More Likely to Die Than Progress to ESRD CKD in the United States Management of The Patient With Chronic Kidney Disease Paul J. Scheel, Jr., M.D., FASN Director,Division of Nephrology An estimated 26 million adults have CKD Many are unaware of

More information

The sensitive marker for glomerular filtration rate (GFR) Estimation of GFR from Serum Cystatin C:

The sensitive marker for glomerular filtration rate (GFR) Estimation of GFR from Serum Cystatin C: The sensitive marker for glomerular filtration rate (GFR) Estimation of GFR from Serum Cystatin C: The good correlation allows close estimation of GFR Cystatin C GFR GFR in serum estimated* measured* n

More information

CLINICAL PRACTICE GUIDELINES. Detection, Monitoring and Care of Patients with CKD. UK Renal Association. Final Version (28.02.

CLINICAL PRACTICE GUIDELINES. Detection, Monitoring and Care of Patients with CKD. UK Renal Association. Final Version (28.02. CLINICAL PRACTICE GUIDELINES Detection, Monitoring and Care of Patients with CKD UK Renal Association 5 th Edition, 2009-2011 Final Version (28.02.2011) Dr Mark S. MacGregor and Dr Maarten W. Taal Posted

More information

Absolute cardiovascular disease risk assessment

Absolute cardiovascular disease risk assessment Quick reference guide for health professionals Absolute cardiovascular disease risk assessment This quick reference guide is a summary of the key steps involved in assessing absolute cardiovascular risk

More information

Use of Glycated Hemoglobin and Microalbuminuria in the Monitoring of Diabetes Mellitus

Use of Glycated Hemoglobin and Microalbuminuria in the Monitoring of Diabetes Mellitus Agency for Healthcare Research and Quality Evidence Report/Technology Assessment Number 84 Use of Glycated Hemoglobin and Microalbuminuria in the Monitoring of Diabetes Mellitus Summary Overview Clinical

More information

John Sharp, MSSA, PMP Manager, Research Informatics Quantitative Health Sciences Cleveland Clinic, Cleveland, Ohio

John Sharp, MSSA, PMP Manager, Research Informatics Quantitative Health Sciences Cleveland Clinic, Cleveland, Ohio John Sharp, MSSA, PMP Manager, Research Informatics Quantitative Health Sciences Cleveland Clinic, Cleveland, Ohio Co-Director BiomedicalResearch Informatics Clinical and Translational Science Consortium

More information

Microalbuminuria: We are in the midst of an epidemic: the epidemic. So What s a Little Protein? Malcolm s diabetes. How much is too much?

Microalbuminuria: We are in the midst of an epidemic: the epidemic. So What s a Little Protein? Malcolm s diabetes. How much is too much? Focus on CME at the University of Saskatchewan Microalbuminuria: So What s a Little Protein? By Judith T. Klassen, BSc, MD, FRCPC University of Saskatchewan Practical Management of Common Medical Problems

More information

Chronic Kidney Disease

Chronic Kidney Disease Page 1 of 6 Chronic Kidney Disease Chronic kidney disease (CKD) means that your kidneys are not working as well as they once did. Various conditions can cause CKD. Severity can vary but most cases are:

More information

The definition, classification and prognosis of chronic kidney disease: a KDIGO Controversies Conference report

The definition, classification and prognosis of chronic kidney disease: a KDIGO Controversies Conference report http://www.kidney-international.org & 2010 International Society of Nephrology public forum The definition, classification and prognosis of chronic kidney disease: a KDIGO Controversies Conference report

More information

Chronic Kidney Disease and Diabetes

Chronic Kidney Disease and Diabetes Anyone with diabetes can get kidney disease. Diabetes and high blood pressure are the most common causes of kidney disease, and people often have both. Chronic (long term) kidney disease (CKD) caused by

More information

Chapter 6: Limitations of Various Formulae and Other Ways of Assessing GFR in the Elderly: Is There a Role for Cystatin C?

Chapter 6: Limitations of Various Formulae and Other Ways of Assessing GFR in the Elderly: Is There a Role for Cystatin C? Chapter 6: Limitations of Various Formulae and Other Ways of Assessing GFR in the Elderly: Is There a Role for Cystatin C? Devraj Munikrishnappa Department of Internal Medicine, The Nephrology Division,

More information

New Cholesterol Guidelines: Carte Blanche for Statin Overuse Rita F. Redberg, MD, MSc Professor of Medicine

New Cholesterol Guidelines: Carte Blanche for Statin Overuse Rita F. Redberg, MD, MSc Professor of Medicine New Cholesterol Guidelines: Carte Blanche for Statin Overuse Rita F. Redberg, MD, MSc Professor of Medicine Disclosures & Relevant Relationships I have nothing to disclose No financial conflicts Editor,

More information

Your Kidneys: Master Chemists of the Body

Your Kidneys: Master Chemists of the Body Your Kidneys: Master Chemists of the Body www.kidney.org National Kidney Foundation's Kidney Disease Outcomes Quality Initiative Did you know that the National Kidney Foundation's Kidney Disease Outcomes

More information

In many diabetes units, people with type

In many diabetes units, people with type Renal Microalbuminuria: Screening and management in type 2 diabetes Julia Arundale Introduction In many diabetes units, patients with type 1 or type 2 diabetes are screened for proteinuria. Screening for

More information

Creatinine (serum, plasma)

Creatinine (serum, plasma) Creatinine (serum, plasma) 1 Name and description of analyte 1.1 Name of analyte Creatinine 1.2 Alternative names None 1.3 Description of analyte Creatinine is a heterocyclic nitrogenous compound (IUPAC

More information

How To Know If Low Protein Diet Is Beneficial For Kidney Health

How To Know If Low Protein Diet Is Beneficial For Kidney Health Protein Intake and Diabetic Kidney Disease Robert C. Stanton Joslin Diabetes Center 1/Serum Creatinine Plot Low Protein Protects in Renal Ablation Model 24% Protein Diet 6% Protein Diet Right Nephrectomy

More information

GUIDELINES FOR THE TREATMENT OF DIABETIC NEPHROPATHY*

GUIDELINES FOR THE TREATMENT OF DIABETIC NEPHROPATHY* 71 GUIDELINES FOR THE TREATMENT OF DIABETIC NEPHROPATHY* Ryuichi KIKKAWA** Asian Med. J. 44(2): 71 75, 2001 Abstract: Diabetic nephropathy is the most devastating complication of diabetes and is now the

More information

Package nephro. February 23, 2015

Package nephro. February 23, 2015 Type Pack Title Biostatistics Utilities for Nephrology Version 1.1 Date 2015-01-31 Author Pack nephro February 23, 2015 Maintainer Set of functions to estimate the Glomerular

More information

Albumin and All-Cause Mortality Risk in Insurance Applicants

Albumin and All-Cause Mortality Risk in Insurance Applicants Copyright E 2010 Journal of Insurance Medicine J Insur Med 2010;42:11 17 MORTALITY Albumin and All-Cause Mortality Risk in Insurance Applicants Michael Fulks, MD; Robert L. Stout, PhD; Vera F. Dolan, MSPH

More information

The contribution of chronic kidney disease to the global burden of major noncommunicable diseases

The contribution of chronic kidney disease to the global burden of major noncommunicable diseases http://www.kidney-international.org & 2011 International Society of Nephrology The contribution of chronic kidney disease to the global burden of major noncommunicable diseases William G. Couser 1, Giuseppe

More information

DIET AND EXERCISE STRATEGIES FOR WEIGHT LOSS AND WEIGHT MAINTENANCE

DIET AND EXERCISE STRATEGIES FOR WEIGHT LOSS AND WEIGHT MAINTENANCE DIET AND EXERCISE STRATEGIES FOR WEIGHT LOSS AND WEIGHT MAINTENANCE 40 yo woman, BMI 36. Motivated to begin diet therapy. Which of the following is contraindicated: Robert B. Baron MD MS Professor and

More information

Ca : methods for determining DRIs. Adults. 4average requirement, meta-analyzed balance studies by FAO/WHO :

Ca : methods for determining DRIs. Adults. 4average requirement, meta-analyzed balance studies by FAO/WHO : Minerals Categories of Ds for Minerals - Ca, P, Na, Cl, K, Mg - Mineral Ca RDA P Ca ; 서울대학교 이연숙 Na P ; 국민대학교 김선희 Na, Cl ; 동의대학교 임화재 K ; 국민대학교 장문정 Mg ; 인하대학교 천종희 Cl K Mg Indicators for Estimating Ds Ca

More information

Kidney Disease WHAT IS KIDNEY DISEASE? TESTS TO DETECT OR DIAGNOSE KIDNEY DISEASE TREATMENT STRATEGIES FOR KIDNEY DISEASE

Kidney Disease WHAT IS KIDNEY DISEASE? TESTS TO DETECT OR DIAGNOSE KIDNEY DISEASE TREATMENT STRATEGIES FOR KIDNEY DISEASE Kidney Disease WHAT IS KIDNEY DISEASE? Kidney disease is when your kidneys are damaged and not functioning as they should. When kidney disease is not going away it is called chronic kidney disease or CKD.

More information

Population health management at Cleveland clinic

Population health management at Cleveland clinic Population health management at Cleveland clinic Sankar D Navaneethan, MD, MS, MPH Using Health Information Technology to Identify and Manage CKD Populations Oct 22-23 2015 Objectives Development of an

More information

Using multiple biomarkers to predict renal and cardiovascular drug efficacy: Implications for drug development and registration

Using multiple biomarkers to predict renal and cardiovascular drug efficacy: Implications for drug development and registration Using multiple biomarkers to predict renal and cardiovascular drug efficacy: Implications for drug development and registration Hiddo Lambers Heerspink Department of Clinical Pharmacology University Medical

More information

DISCLOSURES RISK ASSESSMENT. Stroke and Heart Disease -Is there a Link Beyond Risk Factors? Daniel Lackland, MD

DISCLOSURES RISK ASSESSMENT. Stroke and Heart Disease -Is there a Link Beyond Risk Factors? Daniel Lackland, MD STROKE AND HEART DISEASE IS THERE A LINK BEYOND RISK FACTORS? D AN IE L T. L AC K L AN D DISCLOSURES Member of NHLBI Risk Assessment Workgroup RISK ASSESSMENT Count major risk factors For patients with

More information

Beware that Low Urine Creatinine! by Vera F. Dolan MSPH FALU, Michael Fulks MD, Robert L. Stout PhD

Beware that Low Urine Creatinine! by Vera F. Dolan MSPH FALU, Michael Fulks MD, Robert L. Stout PhD 1 Beware that Low Urine Creatinine! by Vera F. Dolan MSPH FALU, Michael Fulks MD, Robert L. Stout PhD Executive Summary: The presence of low urine creatinine at insurance testing is associated with increased

More information

Urine Protein/Creatinine Ratio as a Mortality Risk Predictor in Non-Diabetics with Normal Renal Function

Urine Protein/Creatinine Ratio as a Mortality Risk Predictor in Non-Diabetics with Normal Renal Function JOURNAL OF INSURANCE MEDICINE Copyright E 2012 Journal of Insurance Medicine J Insur Med 2012;43:76 83 MORTALITY Urine Protein/Creatinine Ratio as a Mortality Risk Predictor in Non-Diabetics with Normal

More information

KIDNEY FUNCTION RELATION TO SIZE OF THE TUMOR IN RENAL CELL CANCINOMA

KIDNEY FUNCTION RELATION TO SIZE OF THE TUMOR IN RENAL CELL CANCINOMA KIDNEY FUNCTION RELATION TO SIZE OF THE TUMOR IN RENAL CELL CANCINOMA O.E. Stakhvoskyi, E.O. Stakhovsky, Y.V. Vitruk, O.A. Voylenko, P.S. Vukalovich, V.A. Kotov, O.M. Gavriluk National Canсer Institute,

More information

QUALITY OF LIFE WITH DIABETES AND CHRONIC KIDNEY DISEASE

QUALITY OF LIFE WITH DIABETES AND CHRONIC KIDNEY DISEASE QUALITY OF LIFE WITH DIABETES AND CHRONIC KIDNEY DISEASE www.kidney.org National Kidney Foundation's Kidney Disease Outcomes Quality Initiative Did you know that the National Kidney Foundation's Kidney

More information

The Stages of Chronic Kidney Disease and the Estimated Glomerular Filtration Rate

The Stages of Chronic Kidney Disease and the Estimated Glomerular Filtration Rate The Stages of Chronic Kidney Disease and the Estimated Glomerular Filtration Rate LAURENCE E. CARROLL, M.D., F.A.S.N. Hypertension Kidney Specialists INTRODUCTION The ability to assess kidney function

More information

survival, morality, & causes of death Chapter Nine introduction 152 mortality in high- & low-risk patients 154 predictors of mortality 156

survival, morality, & causes of death Chapter Nine introduction 152 mortality in high- & low-risk patients 154 predictors of mortality 156 introduction 152 < mortality in high- & low-risk patients 154 < predictors of mortality 156 < impact of anemia & dialysis therapy on mortality 158 < mortality in esrd patients with rare s 16 < expected

More information

Renal Cysts What should I do now?

Renal Cysts What should I do now? Renal Cysts What should I do now? Dr Edmund Chiong Asst. Professor & Consultant Department of Urology National University Hospital What are renal cysts? Fluid-filled structures in the kidney that are not

More information

Kidney Disease: Key Facts and Figures. September 2010

Kidney Disease: Key Facts and Figures. September 2010 Kidney Disease: Key Facts and Figures September 2010 ii Kidney Disease Key Facts and Figures Contents Introduction... 1 1 Kidney disease common definitions... 2 1.1 Chronic kidney disease... 2 1.2 Acute

More information

Renal Function Tests. Carmella L. D Addezio, DO, MS, FACOI, LTC, USAF, MC

Renal Function Tests. Carmella L. D Addezio, DO, MS, FACOI, LTC, USAF, MC Renal Function Tests Carmella L. D Addezio, DO, MS, FACOI, LTC, USAF, MC Goals and objectives At the end of this discussion you will be able to state: What test you should use to screen a patient for renal

More information

Diabetic Ketoacidosis: When Sugar Isn t Sweet!!!

Diabetic Ketoacidosis: When Sugar Isn t Sweet!!! Diabetic Ketoacidosis: When Sugar Isn t Sweet!!! W Ricks Hanna Jr MD Assistant Professor of Pediatrics University of Tennessee Health Science Center LeBonheur Children s Hospital Introduction Diabetes

More information

Epidemiology of Diabetic Kidney Disease

Epidemiology of Diabetic Kidney Disease Epidemiology of Diabetic Kidney Disease Anne T. Reutens, MBBS, PhD, FRACP a,b, * KEYWORDS Diabetes Prevalence Incidence Microalbuminuria Macroalbuminuria End-stage renal disease KEY POINTS Diabetic kidney

More information

Diagnostic Assessments Relating to Renal Function: Why we do them? What do they mean? Mohamud Karim MD, FRCPC. Feb 27, 2015

Diagnostic Assessments Relating to Renal Function: Why we do them? What do they mean? Mohamud Karim MD, FRCPC. Feb 27, 2015 Diagnostic Assessments Relating to Renal Function: Why we do them? What do they mean? Mohamud Karim MD, FRCPC Feb 27, 2015 Acknowledgements: Previous presentor Why are Patients Referred? Renal Syndromes:

More information

High Blood pressure and chronic kidney disease

High Blood pressure and chronic kidney disease High Blood pressure and chronic kidney disease For People with CKD Stages 1 4 www.kidney.org National Kidney Foundation's Kidney Disease Outcomes Quality Initiative Did you know that the National Kidney

More information

Main Effect of Screening for Coronary Artery Disease Using CT

Main Effect of Screening for Coronary Artery Disease Using CT Main Effect of Screening for Coronary Artery Disease Using CT Angiography on Mortality and Cardiac Events in High risk Patients with Diabetes: The FACTOR-64 Randomized Clinical Trial Joseph B. Muhlestein,

More information

Metabolic Syndrome Overview: Easy Living, Bitter Harvest. Sabrina Gill MD MPH FRCPC Caroline Stigant MD FRCPC BC Nephrology Days, October 2007

Metabolic Syndrome Overview: Easy Living, Bitter Harvest. Sabrina Gill MD MPH FRCPC Caroline Stigant MD FRCPC BC Nephrology Days, October 2007 Metabolic Syndrome Overview: Easy Living, Bitter Harvest Sabrina Gill MD MPH FRCPC Caroline Stigant MD FRCPC BC Nephrology Days, October 2007 Evolution of Metabolic Syndrome 1923: Kylin describes clustering

More information

Open the Flood Gates Urinary Obstruction and Kidney Stones. Dr. Jeffrey Rosenberg Dr. Emilio Lastarria Dr. Richard Kasulke

Open the Flood Gates Urinary Obstruction and Kidney Stones. Dr. Jeffrey Rosenberg Dr. Emilio Lastarria Dr. Richard Kasulke Open the Flood Gates Urinary Obstruction and Kidney Stones Dr. Jeffrey Rosenberg Dr. Emilio Lastarria Dr. Richard Kasulke Nephrology vs. Urology Nephrologist a physician who has been trained in the diagnosis

More information

Medicare s Preventive Care Services. Manage Your Chronic Kidney Disease (CKD stages 3-4) with Diet

Medicare s Preventive Care Services. Manage Your Chronic Kidney Disease (CKD stages 3-4) with Diet s Preventive Care Services Manage Your Chronic Kidney Disease (CKD stages 3-4) with Diet What do the kidneys do? Your kidneys have important jobs to do in your body. Two of the kidneys most important jobs

More information

Cardiovascular Risk in Diabetes

Cardiovascular Risk in Diabetes Cardiovascular Risk in Diabetes Lipids Hypercholesterolaemia is an important reversible risk factor for cardiovascular disease and should be tackled aggressively in all diabetic patients. In Type 1 patients,

More information

Type 1 Diabetes ( Juvenile Diabetes)

Type 1 Diabetes ( Juvenile Diabetes) Type 1 Diabetes W ( Juvenile Diabetes) hat is Type 1 Diabetes? Type 1 diabetes, also known as juvenile-onset diabetes, is one of the three main forms of diabetes affecting millions of people worldwide.

More information

Chronic Kidney Disease (CKD) Guideline

Chronic Kidney Disease (CKD) Guideline Chronic Kidney Disease (CKD) These clinical guidelines are designed to assist clinicians by providing an analytical framework for the evaluation and treatment of patients. They are not intended to replace

More information

Chapter 23. Composition and Properties of Urine

Chapter 23. Composition and Properties of Urine Chapter 23 Composition and Properties of Urine Composition and Properties of Urine urinalysis the examination of the physical and chemical properties of urine appearance - clear, almost colorless to deep

More information

SUMMARY OF CHANGES TO QOF 2015/16 - ENGLAND CLINICAL

SUMMARY OF CHANGES TO QOF 2015/16 - ENGLAND CLINICAL SUMMARY OF CHANGES TO QOF 2015/1 - ENGLAND KEY No change Retired/replaced Wording and/or change Point or threshold change Indicator ID change 14/15 QOF ID 15/1 QOF ID NICE ID Indicator wording Changes

More information

Coding to be more efficient and accurate

Coding to be more efficient and accurate Why we need to code well! Coding to be more efficient and accurate Diabetes without Complication Diabetes with opthamologic or unspecified complication Diabetes with acute complication $1833 $2931 $3836

More information

嘉 義 長 庚 醫 院 藥 劑 科 Speaker : 翁 玟 雯

嘉 義 長 庚 醫 院 藥 劑 科 Speaker : 翁 玟 雯 The Clinical Efficacy and Safety of Sodium Glucose Cotransporter-2 (SGLT2) Inhibitors in Adults with Type 2 Diabetes Mellitus 嘉 義 長 庚 醫 院 藥 劑 科 Speaker : 翁 玟 雯 Diabetes Mellitus : A group of diseases characterized

More information

Primary Care Management of Male Lower Urinary Tract Symptoms. Matthew B.K. Shaw Consultant Urological Surgeon

Primary Care Management of Male Lower Urinary Tract Symptoms. Matthew B.K. Shaw Consultant Urological Surgeon Primary Care Management of Male Lower Urinary Tract Symptoms Matthew B.K. Shaw Consultant Urological Surgeon NICE LUTS Guidelines Lower Urinary Tract Symptoms (LUTS) in men. NICE Clinical Guideline 97

More information

New Kidney Allocation and What it Means to Your Transplant Center and Your Patients

New Kidney Allocation and What it Means to Your Transplant Center and Your Patients New Kidney Allocation and What it Means to Your Transplant Center and Your Patients Alexander Wiseman, M.D. Professor, Division of Renal Diseases and Hypertension Medical Director, Kidney and Pancreas

More information

Monitoring the Hemodialysis Dose

Monitoring the Hemodialysis Dose KDIGO Controversies Conference Novel techniques and innovation in blood purification: How can we improve clinical outcomes in hemodialysis? October 14-15, 2011 Paris France Monitoring the Hemodialysis

More information

Insulin is a hormone produced by the pancreas to control blood sugar. Diabetes can be caused by too little insulin, resistance to insulin, or both.

Insulin is a hormone produced by the pancreas to control blood sugar. Diabetes can be caused by too little insulin, resistance to insulin, or both. Diabetes Definition Diabetes is a chronic (lifelong) disease marked by high levels of sugar in the blood. Causes Insulin is a hormone produced by the pancreas to control blood sugar. Diabetes can be caused

More information

Risk Factors of chronic complex co-morbidities. Aldo Pietro Maggioni, MD ANMCO Research Center Firenze, Italy

Risk Factors of chronic complex co-morbidities. Aldo Pietro Maggioni, MD ANMCO Research Center Firenze, Italy Risk Factors of chronic complex co-morbidities Aldo Pietro Maggioni, MD ANMCO Research Center Firenze, Italy Statement 1 In real world practice (and in clinical trials), complex co-morbidities are the

More information

Androgens and CVD. Brandon Orr- Walker April 2014

Androgens and CVD. Brandon Orr- Walker April 2014 Androgens and CVD Brandon Orr- Walker April 2014 Agenda What is normal physiology of Aging? Hypogonadism and disease If some is good is more becer? CVD safety Clinical features of Androgen Deficiency

More information

( Diabetic nephropathy) ( Microalbuminuria ) ( Macroalbuminuria )

( Diabetic nephropathy) ( Microalbuminuria ) ( Macroalbuminuria ) 2006 17 99-105 2006 20-40% ( ESRD ) 30 299 mg ( ) ( 300 mgday ) DCCBs ) dihydropyridine calcium channel blockers ( non- DCCBs ( -blockers ( diuretics ) 10%) 0.8 ( 60 mlmin per 1.73 m 2 30 mlmin per 1.73

More information

ESIM 2014 WHEN CHRONIC BECOMES ACUTE

ESIM 2014 WHEN CHRONIC BECOMES ACUTE ESIM 2014 WHEN CHRONIC BECOMES ACUTE Anna Salina, MD Pauls Stradins Clinical University Hospital Riga, Latvia 37 years old female, 50 kg, 150 cm Complaints Severe edema +8 kg Tiredness, dry cough Chills

More information

INSULIN REQUIREMENT IN DIABETIC PATIENTS WITH CHRONIC RENAL FAILURE DUE TO DIABETIC NEPHROPATHY (DN)

INSULIN REQUIREMENT IN DIABETIC PATIENTS WITH CHRONIC RENAL FAILURE DUE TO DIABETIC NEPHROPATHY (DN) E:/Biomedica/New Journal 2004/Bio-11.doc (A) INSULIN REQUIREMENT IN DIABETIC PATIENTS WITH CHRONIC RENAL FAILURE DUE TO DIABETIC NEPHROPATHY (DN) KAMRAN RASHID, KHALIL UR REHMAN, M. SAEED ANWER AAEISHA

More information

How To Know If You Have Microalbuminuria

How To Know If You Have Microalbuminuria HIPPOKRATIA 2013, 17, 4: 337-341 ORIGINAL ARTICLE Prevalence of microalbuminuria and risk factor analysis in type 2 diabetes patients in Albania: the need for accurate and early diagnosis of diabetic nephropathy

More information

Registered Charity No: 326679 Caring for those with a rare, complex and lifelong disease www.behcets.org.uk

Registered Charity No: 326679 Caring for those with a rare, complex and lifelong disease www.behcets.org.uk Registered Charity No: 326679 Caring for those with a rare, complex and lifelong disease www.behcets.org.uk Behçet s Disease and the Kidneys How are the kidneys affected by Behçet s disease? Kidney disease

More information

Update in Contrast Induced Nephropathy

Update in Contrast Induced Nephropathy Update in Contrast Induced Nephropathy Yves Pirson Service de Néphrologie, Clin. Univ. St-Luc - UCL A 76-year-old man with - type 2 diabetes - CKD (ser. creat.: 1.8 mg/dl; GFR: 32) presents with angina

More information

Corporate Medical Policy

Corporate Medical Policy Corporate Medical Policy File Name: Origination: Last CAP Review: Next CAP Review: Last Review: testing_serum_vitamin_d_levels 9/2015 2/2016 2/2017 2/2016 Description of Procedure or Service Vitamin D,

More information

1. PATHOPHYSIOLOGY OF METABOLIC SYNDROME

1. PATHOPHYSIOLOGY OF METABOLIC SYNDROME 1. PATHOPHYSIOLOGY OF METABOLIC SYNDROME Izet Aganović, Tina Dušek Department of Internal Medicine, Division of Endocrinology, University Hospital Center Zagreb, Croatia 1 Introduction The metabolic syndrome

More information

MANAGEMENT OF LIPID DISORDERS: IMPLICATIONS OF THE NEW GUIDELINES

MANAGEMENT OF LIPID DISORDERS: IMPLICATIONS OF THE NEW GUIDELINES MANAGEMENT OF LIPID DISORDERS: IMPLICATIONS OF THE NEW GUIDELINES Robert B. Baron MD MS Professor and Associate Dean UCSF School of Medicine Declaration of full disclosure: No conflict of interest EXPLAINING

More information

High Blood Pressure and Chronic Kidney Disease

High Blood Pressure and Chronic Kidney Disease High Blood Pressure and Chronic Kidney Disease For People with CKD Stages 1 4 www.kidney.org National Kidney Foundation's Kidney Disease Outcomes Quality Initiative Did you know that the National Kidney

More information